Publications: IBD (8)

2021

Öhman L, Lasson A, Strömbeck A, Isaksson S, Hesselmar M, Simrén M, Strid H, Magnusson MK. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis - PubMed (nih.gov). Sci Rep. 2021 Apr 21;11(1):8641. doi: 10.1038/s41598-021-87973-7. PMID: 33883600; PMCID: PMC8060394.

2020

Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P; Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character) - PubMed (nih.gov). Scand J Gastroenterol. 2020 Oct;55(10).

Strömbeck A, Lasson A, Strid H, et al. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease - PubMed (nih.gov). BMC Gastroenterol. 2020;20(1):130. Published 2020 May 4.

2019

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome - PubMed (nih.gov). Clin Exp Gastroenterol. 2019;12:37-49. Published 2019 Jan 31.

2013

Thorkildsen LT, Nwosu FC, Avershina E, et al. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients - PubMed (nih.gov). Gastroenterol Res Pract. 2013;2013:636785.